Literature DB >> 7121719

Investigations of the lipid metabolism of the white matter in multiple sclerosis: changes in glycero-phosphatides and lipid-splitting enzymes.

I Neu, H Woelk.   

Abstract

Phospho- and galacto- lipids and lipidhydrolyzing enzymes have been determined in the white matter of a young patient with a subacute course of multiple sclerosis (MS). Significant changes were observed for the concentration of glycerophosphatides and the fatty acid pattern of the normal appearing with matter surrounding MS-plaques. Among the individual glycerophosphatides a significant decrease of phosphatidylserine and phosphatidylinositol was found, whereas the ethanolamine containing phosphatides showed lower figures (non significant). The fatty acid pattern of the ethanolamine-phosphatide-fraction of the diseased tissue a decrease of the 18:1 and the sum of 20:1 and 18:3 fatty acids as compared to the normal control, whereas the highly unsaturated, long-chained fatty acids 20:4 (arachidonic acid) and 22:6 (docosahexaenic acid) were elevated. The measurement of lipidhydrolyzing enzymes resulted in an increased phospholipase A1 activity in the diseased tissue. The experimental data point to a decreased activity of the fatty acid elongation system in the course of MS. The decrease of the acidic glycerophosphatides might be due to the increased phospholipase A1 activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7121719     DOI: 10.1007/bf00965525

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  28 in total

1.  SEPARATION OF THE LIPIDS OF PHOTOSYNTHETIC TISSUES: IMPROVEMENTS IN ANALYSIS BY THIN-LAYER CHROMATOGRAPHY.

Authors:  B W NICHOLS
Journal:  Biochim Biophys Acta       Date:  1963-08-27

2.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

3.  Lipid chemistry of the brain in demyelinating diseases.

Authors:  J N CUMINGS
Journal:  Brain       Date:  1955       Impact factor: 13.501

4.  Myelin constituents of human central nervous system.

Authors:  J Clausen; I B Hansen
Journal:  Acta Neurol Scand       Date:  1970       Impact factor: 3.209

5.  The action of brain phospholipases A2 on purified, specifically labelled 1,2-diacyl-, 2-acyl-1-alk-1'-enyl- and 2-acyl-1-alkyl-sn-glycero-3-phosphorylcholine.

Authors:  H Woelk; G Goracci; G Porcellati
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1974-01

6.  Plasmalogenase activity in normal and demyelinating tissue of the central nervous system.

Authors:  G B Ansell; S Spanner
Journal:  Biochem J       Date:  1968-06       Impact factor: 3.857

7.  Enzymic studies on sulphatide metabolism in different stages of experimental allergic encephalomyelitis.

Authors:  N S Vasan; B K Bachhawat
Journal:  J Neurochem       Date:  1971-10       Impact factor: 5.372

8.  [Effect of phospholipase A from snake venom on phosphatidylcholine, phosphatidylethanolamine and on the corresponding plasmalogens. Enzyme kinetic studies].

Authors:  H Woelk; H Debuch
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1971-10

9.  Lipids and proteins in multiple sclerosis white matter.

Authors:  B Gerstl; L F Eng; M Tavaststjerna; J K Smith; S L Kruse
Journal:  J Neurochem       Date:  1970-05       Impact factor: 5.372

10.  [Acid chromatography preparation of phosphatides from brain total lipid extracts].

Authors:  K Harzer; K Sandhoff; H Jatzkewitz
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1967-01
View more
  6 in total

1.  Imaging mass spectrometry of frontal white matter lipid changes in human alcoholics.

Authors:  Suzanne M de la Monte; Jared Kay; Emine B Yalcin; Jillian J Kril; Donna Sheedy; Greg T Sutherland
Journal:  Alcohol       Date:  2017-08-17       Impact factor: 2.405

Review 2.  Is the myelin membrane abnormal in multiple sclerosis?

Authors:  D D Wood; M A Moscarello
Journal:  J Membr Biol       Date:  1984       Impact factor: 1.843

3.  Biochemical changes in Cuprizone-induced spongiform encephalopathy. I. Changes in the activities of 2',3'-cyclic nucleotide 3'-phosphohydrolase, oligodendroglial ceramide galactosyl transferase, and the hydrolysis of the alkenyl group of alkenyl, acyl-glycerophospholipids by plasmalogenase in different regions of the brain.

Authors:  E M Carey; N M Freeman
Journal:  Neurochem Res       Date:  1983-08       Impact factor: 3.996

4.  Machine-Learned Data Structures of Lipid Marker Serum Concentrations in Multiple Sclerosis Patients Differ from Those in Healthy Subjects.

Authors:  Jörn Lötsch; Michael Thrun; Florian Lerch; Robert Brunkhorst; Susanne Schiffmann; Dominique Thomas; Irmgard Tegder; Gerd Geisslinger; Alfred Ultsch
Journal:  Int J Mol Sci       Date:  2017-06-07       Impact factor: 5.923

Review 5.  Precision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive Astrocytes.

Authors:  Pekka Poutiainen; Merja Jaronen; Francisco J Quintana; Anna-Liisa Brownell
Journal:  Front Mol Neurosci       Date:  2016-09-15       Impact factor: 5.639

6.  Machine-learning based lipid mediator serum concentration patterns allow identification of multiple sclerosis patients with high accuracy.

Authors:  Jörn Lötsch; Susanne Schiffmann; Katja Schmitz; Robert Brunkhorst; Florian Lerch; Nerea Ferreiros; Sabine Wicker; Irmgard Tegeder; Gerd Geisslinger; Alfred Ultsch
Journal:  Sci Rep       Date:  2018-10-05       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.